remdesivir drug | Remdesivir

Keyword	CPC	PCC	Volume	Score	Length of keyword
remdesivir drug	1.82	0.4	2081	2	15
remdesivir	0.1	0.2	5353	81	10
drug	1.76	1	9049	50	4

Keyword	CPC	PCC	Volume	Score
remdesivir drug	0.73	0.6	1833	94
remdesivir drug interactions	0.58	0.6	1115	34
remdesivir drug class	0.8	0.1	4373	87
remdesivir drug side effects	0.01	0.7	7279	89
remdesivir drug classification	0.95	0.9	7901	87
remdesivir drug interaction checker	0.58	1	4685	74
remdesivir drug drug interactions	0.71	0.1	154	54
remdesivir drug for covid treatment	0.79	0.1	421	38
remdesivir drug manufacturer	1.06	0.7	665	64
remdesivir drug mce	1.1	0.3	5797	61
remdesivir drug cost	1.92	0.9	195	63
remdesivir drug type	1.07	0.2	6855	30
remdesivir drug for cats	0.47	0.7	3819	97
covid drug remdesivir	0.81	0.5	3848	72
another name for remdesivir drug	0.83	0.1	3560	89
what kind of drug is remdesivir	0.01	1	5839	60
what is remdesivir drug	0.98	0.7	6727	48
covid drug remdesivir side effects	0.7	0.2	395	42

Search Results related to remdesivir drug on Search Engine

Remdesivir - Wikipedia
wikipedia.org

https://en.wikipedia.org/wiki/Remdesivir

WEBRemdesivir, sold under the brand name Veklury, is a broad-spectrum antiviral medication developed by the biopharmaceutical company Gilead Sciences. It is administered via injection into a vein. During the COVID‑19 pandemic, remdesivir was approved or authorized for emergency use to treat COVID‑19 in numerous countries.

DA: 78 PA: 38 MOZ Rank: 24

Remdesivir Uses, Side Effects & Warnings - Drugs.com
drugs.com

https://www.drugs.com/mtm/remdesivir.html

WEBWhat is remdesivir? Remdesivir is used to treat adults and children at least 28 days and older who weigh at least 7 pounds (3 kilograms) with positive results for COVID-19 who are: in a hospital; or. not in a hospital and have mild-to-moderate COVID-19, and are at high risk for progression to severe COVID-19, including hospitalization or death.

DA: 59 PA: 62 MOZ Rank: 38

Remdesivir | COVID-19 Treatment Guidelines
nih.gov

https://www.covid19treatmentguidelines.nih.gov/therapies/antivirals-including-antibody-products/remdesivir/

WEBLast Updated: February 29, 2024. Remdesivir is a nucleotide prodrug of an adenosine analog. It binds to the viral RNA-dependent RNA polymerase and inhibits viral replication by terminating RNA transcription prematurely. Remdesivir has demonstrated in vitro and in vivo activity against SARS-CoV-2. 1.

DA: 6 PA: 71 MOZ Rank: 44

FDA Approves First Treatment for COVID-19 | FDA - U.S. Food and Drug
fda.gov

https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-covid-19

WEBOct 22, 2020 · FDA approved the antiviral drug Veklury (remdesivir) for adults and pediatric patients 12 years of age and older for the treatment of COVID-19 requiring hospitalization. Veklury is the first...

DA: 52 PA: 94 MOZ Rank: 2

Why remdesivir, a highly effective COVID treatment, is a last ... - NPR
npr.org

https://www.npr.org/sections/health-shots/2022/02/07/1078012530/why-remdesivir-a-highly-effective-treatment-is-a-last-resort-for-providers

WEBFeb 7, 2022 · For starters, remdesivir is a drug infusion that must be given intravenously, in a clinical setting. Compared with other outpatient options, the drug takes more space and staff to infuse,...

DA: 87 PA: 35 MOZ Rank: 34

Remdesivir: Uses, Interactions, Mechanism of Action | DrugBank …
drugbank.com

https://go.drugbank.com/drugs/DB14761

WEBApr 23, 2019 · Remdesivir is a nucleoside analog used to treat RNA virus infections including COVID-19. Brand Names. Veklury. Generic Name. Remdesivir. DrugBank Accession Number. DB14761. Background.

DA: 5 PA: 34 MOZ Rank: 39

Final report confirms remdesivir benefits for COVID-19
nih.gov

https://www.nih.gov/news-events/nih-research-matters/final-report-confirms-remdesivir-benefits-covid-19

WEBOctober 20, 2020. Final report confirms remdesivir benefits for COVID-19. At a Glance. The antiviral remdesivir shortened recovery time for patients hospitalized with COVID-19, based on results from the completed trial. Researchers are now testing remdesivir in combination with antibodies and other medications.

DA: 41 PA: 3 MOZ Rank: 58

FDA’s approval of Veklury (remdesivir) for the treatment of …
fda.gov

https://www.fda.gov/drugs/news-events-human-drugs/fdas-approval-veklury-remdesivir-treatment-covid-19-science-safety-and-effectiveness

WEBToday, FDA approved Veklury (remdesivir), the first drug approved to treat COVID-19, for use in adults and pediatric patients 12 years of age and older and weighing at least 40 kg (about 88...

DA: 69 PA: 45 MOZ Rank: 16

Veklury (remdesivir) | HHS/ASPR
hhs.gov

https://aspr.hhs.gov/COVID-19/Therapeutics/Products/Veklury/Pages/default.aspx

WEBVeklury (remdesivir) is an antiviral drug that has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults and pediatric patients (28 days of age and older and weighing at least 3 kg).

DA: 52 PA: 52 MOZ Rank: 13

Remdesivir for the Treatment of Covid-19 — Final Report
nejm.org

https://www.nejm.org/doi/full/10.1056/NEJMoa2007764

WEBMay 22, 2020 · Remdesivir (GS-5734), an inhibitor of the viral RNA-dependent, RNA polymerase with in vitro inhibitory activity against SARS-CoV-1 and the Middle East respiratory syndrome (MERS-CoV), 5-8 was...

DA: 51 PA: 36 MOZ Rank: 13